Cite
MLA Citation
Massimo Bernardi et al.. “Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs.” American journal of hematology, vol. 91, no. 6, n.d., pp. E302–E303. http://access.bl.uk/ark:/81055/vdc_100032419486.0x00005f